Ondansetron vs dexamethasone for chemotherapy-induced emesis.
D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D003907:Dexamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008727:Methotrexate / Q000009:adverse effects; D009325:Nausea / Q000188:drug therapy / Q000191:economics; D017294:Ondansetron; D014750:Vincristine / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D007093:Imidazoles; D001761:Bleomycin; D017294:Ondansetron; D014750:Vincristine; D003907:Dexamethasone; D002945:Cisplatin; D008727:Methotrexate